Cerebrolysin Research Guide

Full name: Cerebrolysin (Brain-Derived Peptide Preparation)

A multi-peptide preparation from porcine brain containing neurotrophic factors. Approved in 40+ countries for stroke and dementia, providing a cocktail of low-MW neuropeptides.

How Cerebrolysin Works

Contains fragments mimicking NGF, BDNF, GDNF, CNTF. Enhances synaptic plasticity, promotes neuronal sprouting, reduces amyloid-beta, and stabilizes calcium homeostasis.

Dosing Protocol

• Typical dose: 5-30 mL
• Frequency: Daily for 10-20 days
• Duration: 10-20 day courses, 2-4x yearly
• Route: Intramuscular or IV

Reported Benefits

• Neurotrophic support
• Stroke recovery
• Memory improvement
• Neuroprotection
• Synaptic plasticity
• Approved in 40+ countries

Potential Side Effects

• Injection pain
• Dizziness
• Headache
• Agitation
• Allergic reaction (porcine)

Research Citations

1. Cerebrolysin in acute ischemic stroke (CASTA) (2020) - 30mL daily for 10 days improved neurological recovery at 90 days in moderate-severe stroke.
2. Cerebrolysin in Alzheimer disease (2021) - Six-month courses stabilized ADAS-Cog scores vs progressive decline in placebo over 28 weeks.

Related Cognitive & Nootropic Compounds

• Selank - Full Profile
• Semax - Full Profile
• Dihexa - Full Profile
• NSI-189 - Full Profile
• P21 - Full Profile
• FGL - Full Profile

View full Cerebrolysin profile with 3D molecule viewer →